Silence Therapeutics - 53 Year Dividend History | SLN
Historical dividend payout and yield for Silence Therapeutics (SLN) since 1971. The current TTM dividend payout for Silence Therapeutics (SLN) as of November 21, 2024 is $0.00. The current dividend yield for Silence Therapeutics as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.210B |
$0.032B |
|
Silence Therapeutics plc focuses on the discovery, development and delivery of novel RNA therapeutics in hematology, cardiovascular and other rare and metabolic indications. The Company's product candidate consist SLN124 for the treatment of iron overload disorders; SLN360 for the cardiovascular disease with high lipoprotein and SLN500 for the treatment of complement-mediated diseases which are in clinical stage. Silence Therapeutics plc is based in London, the United Kingdom.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
